冠状动脉CT血管成像中的斑块进展将非酒精性脂肪性肝病与心血管事件联系起来:一项前瞻性单中心研究
本研究前瞻性纳入1683例无症状参与者,均接受基线和随访冠状动脉CT血管成像(CCTA)。非酒精性脂肪性肝病(NAFLD)组随访CCTA斑块进展发生率高于非NAFLD组(33.0% vs 16.6%,p<0.001),且9.7年无事件生存率更低(66.4% vs 80.9%,log-rank p<0.001)。调整协变量后NAFLD与主要不良心血管事件(MACEs)显著相关(HR=1.63,95%CI 1.28-2.06,p<0.001),但进一步调整斑块进展后该关联不再显著(HR=1.10,95%CI 0.84-1.45,p=0.496);中介分析显示斑块进展中介了99.8%(p=0.002)的关联。
要点
- NAFLD患者随访CCTA斑块进展发生率33.0%(248/752),高于无NAFLD者的16.6%(155/931),p<0.001。
- NAFLD与MACEs显著相关(HR=1.63,95%CI 1.28-2.06),但调整斑块进展后不再显著(HR=1.10,95%CI 0.84-1.45)。
- 斑块进展中介了NAFLD与MACEs之间99.8%(p=0.002)的关联,提示随访CCTA斑块进展是重要中介因素。
核心结论
- 随访CCTA识别的斑块进展中介了NAFLD与MACEs之间的关系。
研究设计与样本
- 前瞻性单中心研究,纳入1683例无症状参与者(平均年龄63.3±9.4岁,范围38-85岁;男性1117例),均接受基线和随访CCTA,分为NAFLD组和非NAFLD组,主要终点为MACEs(全因死亡、非致死性心肌梗死、因急性冠脉综合征导致血运重建的非计划住院的复合终点)。
关键影像表现/征象
- 随访CCTA显示NAFLD组斑块进展发生率为33.0%(248/752),非NAFLD组为16.6%(155/931),p<0.001。
- NAFLD组9.7年无事件生存率为66.4%,非NAFLD组为80.9%,log-rank p<0.001。
诊断标准与关键数值
- 斑块进展由随访CCTA确定。
- NAFLD与MACEs的关联:调整协变量后HR=1.63(95%CI 1.28-2.06,p<0.001);进一步调整斑块进展后HR=1.10(95%CI 0.84-1.45,p=0.496)。
- 中介分析:斑块进展的间接效应β=0.0587(95%CI 0.0424-0.08,p<0.001),中介比例为99.8%(p=0.002)。
临床应用与阅片要点
- 在无症状人群中,随访CCTA发现的斑块进展可能为NAFLD与MACEs之间的关联提供影像学中介信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The presence of non-alcoholic fatty liver disease (NAFLD) has been associated with major adverse cardiovascular events (MACEs); however, the mechanisms that initiate the risk for MACEs in patients with NAFLD remain unknown. We sought to investigate whether plaque progression (PP), determined by coronary CT angiography (CCTA), moderate the relationship between NAFLD and MACEs.
METHODS: A total of 1683 asymptomatic participants (mean age, 63.3 ± 9.4 [range, 38-85] years; 1117 men) who underwent baseline and follow-up CCTA examination were prospectively included in our study. All of the participants were divided into the NAFLD and non-NAFLD groups. PP was determined by follow-up CCTA. The primary endpoint was MACEs, defined as the composite of all-cause death, nonfatal myocardial infarction, and unplanned hospitalization for acute coronary syndrome leading to revascularization.
RESULTS: At follow-up CCTA, participants with NAFLD showed higher incidence of PP than those without [33.0% (248/752) vs. 16.6% (155/931), p < 0.001]. Compared with non-NAFLD participants, participants with NAFLD had a lower 9.7-year event-free survival rate (80.9 vs. 66.4%, log-rank p < 0.001). Cox regression analysis revealed NAFLD was significantly associated with MACEs (HR = 1.63, 95% CI: 1.28 to 2.06, p < 0.001) after adjusting for covariables. However, this association was no longer significant after adjustment for PP (HR = 1.10, 95% CI: 0.84 to 1.45, p = 0.496). The mediation analysis revealed that PP had a significant indirect effect (β = 0.0587, 95% CI: 0.0424 to 0.08, p < 0.001) and mediated 99.8% (p = 0.002) for the relationship between NAFLD and MACEs.
CONCLUSIONS: Plaque progression, identified by follow-up CCTA, mediates the relationship between NAFLD and MACEs.
KEY POINTS: The incidence of CCTA-identified PP was higher for participants with NAFLD than those without NAFLD (248/752 [33.0%] vs. 155/931 [16.6%], p < 0.001). Participants with NAFLD had a lower 9.7-year event-free survival rate than those without NAFLD (66.4% vs. 80.9%, log-rank p < 0.001). The mediation analysis revealed that PP had a significant indirect effect (β = 0.0587, 95% CI: 0.0424 to 0.08, p < 0.001) and mediated 99.8% (p = 0.002) for the relationship between NAFLD and MACEs.
引用
- Yu, Tang, Zhao, et al. Plaque progression at coronary CT angiography links non-alcoholic fatty liver disease and cardiovascular events: a prospective single-center study. Eur Radiol. 2022. PMID: 35727319. doi:10.1007/s00330-022-08904-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。